JP2010512339A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512339A5
JP2010512339A5 JP2009540465A JP2009540465A JP2010512339A5 JP 2010512339 A5 JP2010512339 A5 JP 2010512339A5 JP 2009540465 A JP2009540465 A JP 2009540465A JP 2009540465 A JP2009540465 A JP 2009540465A JP 2010512339 A5 JP2010512339 A5 JP 2010512339A5
Authority
JP
Japan
Prior art keywords
medicament
compound according
manufacture
mammal
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009540465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512339A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086567 external-priority patent/WO2008073789A1/en
Publication of JP2010512339A publication Critical patent/JP2010512339A/ja
Publication of JP2010512339A5 publication Critical patent/JP2010512339A5/ja
Withdrawn legal-status Critical Current

Links

JP2009540465A 2006-12-11 2007-12-06 Ampa受容体増強剤 Withdrawn JP2010512339A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06380319 2006-12-11
US88856207P 2007-02-07 2007-02-07
PCT/US2007/086567 WO2008073789A1 (en) 2006-12-11 2007-12-06 Ampa receptor potentiators

Publications (2)

Publication Number Publication Date
JP2010512339A JP2010512339A (ja) 2010-04-22
JP2010512339A5 true JP2010512339A5 (enExample) 2011-01-27

Family

ID=39272878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540465A Withdrawn JP2010512339A (ja) 2006-12-11 2007-12-06 Ampa受容体増強剤

Country Status (10)

Country Link
US (1) US8097652B2 (enExample)
EP (1) EP2102153A1 (enExample)
JP (1) JP2010512339A (enExample)
KR (1) KR20090082278A (enExample)
CN (1) CN101541741A (enExample)
AU (1) AU2007333247B2 (enExample)
CA (1) CA2672462A1 (enExample)
EA (1) EA015600B1 (enExample)
MX (1) MX2009006243A (enExample)
WO (1) WO2008073789A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2603513B1 (en) 2010-08-10 2020-03-11 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
US9527807B2 (en) 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
JP7085242B2 (ja) * 2017-12-21 2022-06-16 深▲チェン▼市塔吉瑞生物医薬有限公司 キナーゼ活性を阻害するためのアリールホスフィンオキシド
PH12022550597A1 (en) 2019-09-16 2024-03-04 Takeda Pharmaceuticals Co Azole-fused pyridazin-3(2h)-one derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
WO2001090057A1 (en) * 2000-05-19 2001-11-29 Eli Lilly And Company Sulfonamide derivatives

Similar Documents

Publication Publication Date Title
JP2009502743A5 (enExample)
JP2009545527A5 (enExample)
JP2013525444A5 (enExample)
JP2012532874A5 (enExample)
JP2007145875A5 (enExample)
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
JP2011518833A5 (enExample)
JP2009502793A5 (enExample)
JP2006514012A5 (enExample)
JP2006515626A5 (enExample)
JP2014507446A5 (enExample)
JP2007527914A5 (enExample)
JP2013522326A5 (enExample)
FI2291080T5 (fi) Uusia sfingosiinifosfaattireseptorimodulaattoreita
JP2006526031A5 (enExample)
JP2007522220A5 (enExample)
JP2014515013A5 (enExample)
JP2013509429A5 (enExample)
JP2013518107A5 (enExample)
JP2011505356A5 (enExample)
JP2012519182A5 (enExample)
JP2007302689A5 (enExample)
JP2008513510A5 (enExample)
JP2020097577A5 (enExample)
JP2016537338A5 (enExample)